Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Drug tablet price jumps more than $700 overnight

The drug treats life-threatening parasitic infections.

Doctors are outraged after Turing Pharmaceuticals increased the cost of the drug Daraprim from $13.50 a tablet to $750 overnight, The New York Times reported.

Daraprim, a 62-year-old drug, is used by infectious disease specialists to treat life-threatening parasitic infections.

Dr. Judith Aberg, the chief of the division of infectious diseases at the Icahn School of Medicine at Mount Sinai, told the news outlet that the increase may mean the use of " alternative therapies that may not have the same efficacy.”

Turing Pharmaceuticals, a start-up run by a former hedge fund manager, acquired the drug in August.

They say the price increase is a matter of business.

"This isn’t the greedy drug company trying to gouge patients, it is us trying to stay in business,” Martin Shkreli, the founder and chief executive of Turing, told the Times. "It really doesn’t make sense to get any criticism for this.”

In an unexpected turn of events, several days after the story was published, Turing decided to roll back the price of the drug, according to Reuters. It was not immediately clear what the new price would be. 

 

Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.
Download Now
Researched List: Blister Machines for Life Sciences
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?